Key result
Liquid biopsy-based approaches using mass spectrometry for novel biomarkers represent a revolutionary step towards minimally invasive diagnostics and monitoring for Duchenne muscular dystrophy.
This editorial highlights the promise of liquid biopsy-based serum biomarkers for improving early diagnosis and management of Duchenne Muscular Dystrophy, especially in resource-poor settings.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Daniel Matovu (2025) conducted an editorial in Duchenne muscular dystrophy. Serum biomarkers (CA3, FABP3, titin fragments) was evaluated. Liquid biopsy-based approaches using mass spectrometry for novel biomarkers represent a revolutionary step towards minimally invasive diagnostics and monitoring for Duchenne muscular dystrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: